Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis

Infection and Immunity

Volumn 69, Issue 3, 2001, Pages 1895-1901

  Pier, G B ^a   Coleman, F ^a   Grout, M ^a   Franklin, M ^a   Ohman, D E ^a  

^a CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID;

ACETYLATION; ARTICLE; BACTERIAL COUNT; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYSTIC FIBROSIS; IMMUNE RESPONSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACETYLATION; ALGINATES; BACTERIAL CAPSULES; COMPLEMENT ACTIVATION; COMPLEMENT PATHWAY, ALTERNATIVE; CYSTIC FIBROSIS; HUMANS; LUNG DISEASES; OPSONIN PROTEINS; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0035114574     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.3.1895-1901.2001     Document Type: Article

References (48)

1. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide
2. Two distinct loci affecting conversion to mucoidy in Pseudomonas aeruginosa in cystic fibrosis encode homologs of the serine protease HtrA
3. Pseudomonas aeruginosa in cystic fibrosis: Role of mucC in the regulation of alginate production and stress sensitivity
4. Cloning of Pseudomonas aeruginosa algG, which controls alginate structure
5. Genetic analysis of the alginate biosynthetic gene cluster of Pseudomonas aeruginosa shows evidence of an operonic structure
6. Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa
7. The involvement of cell-to-cell signals in the development of a bacterial biofilm
8. Quorum sensing, gene expression, and Pseudomonas biofilms
9. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection
10. Mucoid Pseudomonas aeruginosa in cystic fibrosis - Mutations in the muc loci affect transcription of the algR and algD genes in response to environmental stimuli
11. Conversion to mucoidy in Pseudomonas aeruginosa
12. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: Environmental stress and regulation of bacterial virulence by alternative sigma factors
13. Mucoid-to·nonmucoid conversion in alginate-producing Pseudomonas aeruginosa often results from spontaneous mutations in algT, encoding a putative alternate sigma factor, and shows evidence for autoregulation
14. Identification of algF in the alginate biosynthetic gene cluster of Pseudomonas aeruginosa which is required for alginate acetylation
15. Identification of algI and algJ in the Pseudomonas aeruginosa alginate biosynthetic gene cluster which are required for alginate O acetylation
16. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide
17. Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate
18. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: A class of serum-sensitive, nontypeable strains deficient in lipopolysaccharide O side chains
19. Binding of C3b proceeds by a transesterification reaction at the thiolester site
20. Hypochlorite scavenging by Pseudomonas aeruginosa alginate
21. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): Reversal by physicochemical, alginase, and specific monoclonal antibody treatments
22. Characterization of a locus determining the mucoid status of Pseudomonas aeruginosa: AlgU shows sequence similarities with a Bacillus sigma factor
23. Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients
24. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: A mechanism for virulence activation in the cystic fibrosis lung
25. Posttranslational control of the algT (algU)-encoded sigma22 for expression of the alginate regulon in Pseudomonas aeruginosa and localization of its antagonist proteins MucA and MucB (AlgN)
26. Alginate synthesis by Pseudomonas aeruginosa: A key pathogenic factor in chronic pulmonary infection of cystic fibrosis patients
27. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients
28. Genetic mapping of chromosomal determinants for the production of the exopolysaccharide algihate in a Pseudomonas aeruginosa cystic fibrosis isolate
29. Molecular analysis of the genetic switch activating alginate production
30. Polyagglutinability due to loss of O-antigenic determinants in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
31. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
32. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype
33. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis
34. The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis
35. Mediation of the killing of rough, mucoid isolates of Pseudomonas aeruginosa from patients with cystic fibrosis by the alternative pathway of complement
36. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine
37. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins
38. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older, non-colonized cystic fibrosis patients
39. Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infection
40. Chemistry and biology of the alginate of mucoid strains of Pseudomonas aeruginosa in cystic fibrosis
41. The purification and chemical characterisation of the alginate present in extracellular material produced by mucoid strains of Pseudomonas aeruginosa
42. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
43. An immunohistological evaluation of Pseudomonas aeruginosa pulmonary infection in two patients with cystic fibrosis
44. Positive correlation of algD transcription to lasB and lasA transcription by populations of Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis
45. Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa
46. Purification and characterization of phosphomannomutase/phosphoglucomutase from Pseudomonas aeruginosa involved in biosynthesis of both alginate and lipopolysaccharide
47. Functional equivalence of Escherichia coli sigma E and Pseudomonas aeruginosa AlgU; E. coli rpoE restores mucoidy and reduces sensitivity to reactive oxygen intermediates in algU mutants of P. aeruginosa
48. Alginate synthesis in Pseudomonas aeruginosa - Environmental regulation of the algC promoter